One rejection of MDMA therapy doesn’t mean it’s entirely useless in a mental health context

Post-traumatic stress disorder can be a debilitating condition. There are very few effective treatments.

The question now is whether this rejection will be a setback for psychedelic drugs in general, or if the findings of some unusual research by an unusual company are simply an outlier. But the FDA advisory group expressed some serious reservations about the methodology, which made them doubt the results. Nine out of 11 committee members voted that the Lykos trials did not prove MDMA’s therapeutic effectiveness. In addition, 10 voted that its benefits did not outweigh the risks of using it.

Finally, there is the thorny issue of blinding. In typical randomized clinical trials, half the participants receive the drug being tested, and the other half receive a placebo. But with a psychedelic drug like MDMA, it’s fairly obvious to the participant if they have received a sugar pill. This is a significant challenge for all psychedelics research.

We also have to make a distinction between recreational and therapeutic use of these drugs. MDMA has been a staple of raves and dance parties since the mid-80s. As drugs go, it’s relatively safe.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA advisors oppose MDMA treatment for PTSDPharmaceutical companies focused on psychedelics are under pressure after a Food and Drug Administration (FDA) panel voted against adopting MDMA treatment...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »

Bid To Approve MDMA As PTSD Treatment Overwhelmingly Rejected By FDA AdvisorsThe decision could prove a major setback for advocates who have pushed for the therapeutic use of certain banned substances.
Source: HuffPostCanada - 🏆 61. / 53 Read more »

FDA panel reviews psychedelic drug MDMA for the first timeThe treatment, a capsule form of MDMA, is intended to be administered to patients in combination with talk therapy sessions by a licensed mental health provider
Source: globeandmail - 🏆 5. / 92 Read more »

Psychedelic drug MDMA faces questions as FDA considers approval for PTSDWASHINGTON (AP) — Federal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »

US FDA staff flags concerns on MDMA-assisted PTSD treatmentExplore stories from Atlantic Canada.
Source: SaltWire Network - 🏆 45. / 63 Read more »